GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Resmed Inc. (RMD) [hlAlert]

Rating:
Outperform
RMD
up 64.85 %

Resmed Inc. (RMD) rated Outperform by Credit Suisse

Posted on: Tuesday,  Oct 13, 2009  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Resmed Inc. (NYSE: RMD) on 10/13/2009, when the stock price was $24.19. Since then, Resmed Inc.
has gained 64.85% of its value until Credit Suisse rated RMD Neutral on 10/26/2012, when the price was $39.87.
If you would have followed this Credit Suisse's recommendation on RMD, you would have gained 64.85% of your investment in 1109 days.

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/22/2016 10:25 AM Buy
None
59.16
as of 12/31/2009
1 Week up  22.09 %
1 Month up  27.31 %
3 Months up  32.31 %
1 YTD up  32.31 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/26/2012 10:25 AM Hold
None
39.87
10/13/2009 8:25 AM Buy
None
24.19

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy